Raleigh-based WakeMed has agreed to pay $8 million to settle an investigation into its practice of billing Medicare for expensive overnight hospital stays even though the patients had been treated and discharged the same day.
Last week, biotechnology giant Amgen agreed to pay some $762 million to resolve claims involving unlawful marketing of the anemia drug Aranesp. Federal prosecutors charged Amgen with illegally marketing Aranesp for unapproved uses even after the Food and Drug Administration (“FDA”) expressly ruled them out.
The Pew Charitable Trust has released a report on the use of arbitration clauses in financial institution customer agreements. The Pew report found that there is overwhelming consumer dissatisfaction with the arbitration process, with consumers finding a majority of the typical procedural components of the arbitration process inconvenient or unduly burdensome.
In April CFPB began work on the study by submitting to the Federal Register for publication a “Request for Information Regarding Scope, Methods, and Data Sources for Conducting Study of Pre-Dispute Arbitration Agreements.”
Baylor University Medical Center in Dallas has agreed to pay more than $900,000 to resolve charges that it submitted false claims to Medicare for radiation oncology services.
On November 27, 2012, President Barack Obama signed into law the Whistleblower Protection Enforcement Act, a law that provides federal whistleblowers new and expanded protections. The law upgrades existing safeguards for federal employees who witness and report fraud, abuse, or waste within the federal government.